Tag: Cardiol Therapeutics Inc. (NASDAQ:CRDL)

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 95.68%.However, over the last six months, we can see a

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 90.31%. However, over the last six months,